Bridge to Life Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 96

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $110M

  • Investors
  • 3

Bridge to Life General Information

Description

Developer of preservation products and technologies designed to focus on innovation in organ preservation and machine perfusion. The company uses preservation technologies to improve organ transplants through licensing and developing new preservation solutions for organ transplants, enabling organ procurement organizations and transplant centers to store intra-abdominal organs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3300 Breckinridge Boulevard
  • Suite 200
  • Duluth, GA 30096
  • United States
+1 (800)
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 3300 Breckinridge Boulevard
  • Suite 200
  • Duluth, GA 30096
  • United States
+1 (800)

Bridge to Life Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bridge to Life Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series C) 12-Aug-2026 $110M Completed Generating Revenue
7. Secondary Transaction - Private 01-Aug-2026 Completed Generating Revenue
6. Later Stage VC 28-Aug-2024 Completed Generating Revenue
5. Later Stage VC (Series A) 18-Aug-2021 Completed Generating Revenue
4. Debt - General 06-Jun-2021 Completed Generating Revenue
3. Early Stage VC 16-Mar-2009 Completed Generating Revenue
2. Grant 13-Nov-2008 $50K $538K Completed Generating Revenue
1. Angel (individual) 13-Jan-2006 $538K $538K Completed Generating Revenue
To view Bridge to Life’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Bridge to Life Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of preservation products and technologies designed to focus on innovation in organ preservation and machine pe
Medical Supplies
Duluth, GA
96 As of 2026

Rochester, MN
 

Ithaca, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bridge to Life Competitors (5)

One of Bridge to Life’s 5 competitors is Waters Medical Systems, a Private Equity-Backed company based in Rochester, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Waters Medical Systems Private Equity-Backed Rochester, MN
Transonic Private Debt Financed Ithaca, NY
Paragonix Formerly VC-backed North Waltham, MA
TransMedics Group Formerly VC-backed Andover, MA
OrganOx Formerly PE-Backed Oxford, United Kingdom
You’re viewing 5 of 5 competitors. Get the full list »

Bridge to Life Patents

Bridge to Life Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3233704-A1 Organ preservation system with automatic priming and air removal Pending 06-Oct-2021
EP-4412452-A1 Organ preservation system with automatic priming and air removal Pending 06-Oct-2021
US-11432543-B1 Organ preservation system with automatic priming and air removal Active 06-Oct-2021
WO-2023060012-A1 Organ preservation system with automatic priming and air removal Inactive 06-Oct-2021
EP-4027784-A1 Organ preservation perfusion pump with spectral imaging Pending 11-Sep-2019 A01N1/143
To view Bridge to Life’s complete patent history, request access »

Bridge to Life Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bridge to Life Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lauxera Capital Partners Growth/Expansion Minority
Soleus Capital Asset Manager Minority
Angel (individual) Minority
To view Bridge to Life’s complete investors history, request access »

Bridge to Life Investments & Acquisitions (2)

Bridge to Life’s most recent deal was a Corporate Asset Purchase with Grouppo Medica (Hypothermic Oxygenated Machine Perfusion System). The deal was made on 18-Dec-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Grouppo Medica (Hypothermic Oxygenated Machine Perfusion System) 18-Dec-2024 Corporate Asset Purchase Buildings and Property
Tevosol 09-Feb-2021 Merger/Acquisition Diagnostic Equipment
To view Bridge to Life’s complete investments and acquisitions history, request access »

Bridge to Life FAQs

  • When was Bridge to Life founded?

    Bridge to Life was founded in 2005.

  • Where is Bridge to Life headquartered?

    Bridge to Life is headquartered in Duluth, GA.

  • What is the size of Bridge to Life?

    Bridge to Life has 96 total employees.

  • What industry is Bridge to Life in?

    Bridge to Life’s primary industry is Medical Supplies.

  • Is Bridge to Life a private or public company?

    Bridge to Life is a Private company.

  • What is Bridge to Life’s current revenue?

    The current revenue for Bridge to Life is .

  • How much funding has Bridge to Life raised over time?

    Bridge to Life has raised $187M.

  • Who are Bridge to Life’s investors?

    Lauxera Capital Partners, Soleus Capital, and have invested in Bridge to Life.

  • Who are Bridge to Life’s competitors?

    Waters Medical Systems, Transonic, Paragonix, TransMedics Group, and OrganOx are competitors of Bridge to Life.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process